Position in AZN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$11,464,804
New position
Shares Held
60,462
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#292
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $123,482,590 across 10 Drug Manufacturers - General names. AZN ranks #5 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,866 | $26,226,738 | |
| 2 | JNJ |
Johnson & Johnson
|
90,804 | $23,061,491 | |
| 3 | ABBV |
AbbVie Inc.
|
89,306 | $22,472,961 | |
| 4 | MRK |
Merck & Co., Inc.
|
105,147 | $13,511,389 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
60,462 | $11,464,804 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,781 | $8,058,091 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
136,299 | $7,853,548 | |
| 8 | PFE |
Pfizer Inc
|
286,435 | $6,897,354 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,464,804 | 60,462 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||